SurgiMend Mesh at the Hiatus
Primary Purpose
Hiatal Hernia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SurgiMend Mesh
Sponsored by
About this trial
This is an interventional other trial for Hiatal Hernia
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of type 3 or 4 hiatal hernia (8)
- Subject is able to give informed consent
- Adults at least 18 years of age
Exclusion Criteria:
- Currently pregnant
- Prior hiatal hernia repair
- Prior gastric surgery
- Prior foregut surgery
- Known esophageal dysfunction or dysmotility
- Cirrhosis or ascites
- Known malignancy
- Known allergy to biologic mesh
- Known allergy to barium or other contrast material used in UGI
- Religious objection to animal implant
- Cognitive impairment
- Prisoners
Sites / Locations
- Kettering Health Network - Grandview Medical Center
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
SurgiMend Mesh
Arm Description
SurgiMend Mesh - FDA approved noncross-linked bovine dermis biologic mesh. SurgiMend Mesh will be used according to FDA approved recommendations for the use of abdominal wall hernia reinforcement. SurgiMend is intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend is specifically indicated for: Hernia repair including abdominal, inguinal, femoral, diaphragmatic, scrotal, umbilical, and incisional hernias.
Outcomes
Primary Outcome Measures
Recurrence Rate
Recurrence rate will be analyzed by a Upper gastrointestinal tract radiography (UGI) and clinical evaluation in conjunction with patient's reported physiological assessment per the GERD-HRQL.
Secondary Outcome Measures
Quality of Life Using GERD-HRQL Scale
The GERD-HRQL was initially developed to measure the typical symptoms of GERD and their effect on a patient's quality of life. It was initially determined to have face validity and subsequent studies assessed its content validity and criterion validity. Reliability was determined by the test-retest method. This instrument is practical, with little administrative burden and has been validated for use via the telephone call. Scale is 0-5 with 0 being no symptoms and 5 being symptoms are incapacitating.
Full Information
NCT ID
NCT04282720
First Posted
February 21, 2020
Last Updated
October 4, 2023
Sponsor
Kettering Health Network
Collaborators
Integra LifeSciences Corporation
1. Study Identification
Unique Protocol Identification Number
NCT04282720
Brief Title
SurgiMend Mesh at the Hiatus
Official Title
Hiatal Hernia Repair Using Surgimend Mesh: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
March 31, 2020 (Actual)
Primary Completion Date
August 16, 2023 (Actual)
Study Completion Date
September 5, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kettering Health Network
Collaborators
Integra LifeSciences Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective, single-arm, open-label study to evaluate re-occurrence and quality of life in subjects undergoing primary Hiatal hernia repair using SurgiMend biological mesh. Up to 15, with a target of 10, subjects are planned to be enrolled at one site. All subjects will receive the SurgiMend mesh during surgery. Data collected will be compared to historical data.
Subjects will complete a pre-operative visit. After surgery, in addition to any standard of care visits, subjects will complete 3- and 6-month follow-ups involving a phone QOL survey and will have an upper GI series at 6 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hiatal Hernia
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
9 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SurgiMend Mesh
Arm Type
Other
Arm Description
SurgiMend Mesh - FDA approved noncross-linked bovine dermis biologic mesh. SurgiMend Mesh will be used according to FDA approved recommendations for the use of abdominal wall hernia reinforcement.
SurgiMend is intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend is specifically indicated for:
Hernia repair including abdominal, inguinal, femoral, diaphragmatic, scrotal, umbilical, and incisional hernias.
Intervention Type
Device
Intervention Name(s)
SurgiMend Mesh
Intervention Description
Following placement of SurgiMend mesh during laparoscopic hiatal hernia repair, patient will be scheduled for follow up using an upper GI series to check for recurrence of the hiatal hernia. Follow up upper GIs will be performed at 6 months post-surgery. Subjects will also complete a QOL survey to assess other GI associated symptoms before and after surgical repair. The QOL survey can be administered by phone by study team members
Primary Outcome Measure Information:
Title
Recurrence Rate
Description
Recurrence rate will be analyzed by a Upper gastrointestinal tract radiography (UGI) and clinical evaluation in conjunction with patient's reported physiological assessment per the GERD-HRQL.
Time Frame
6 months post surgery
Secondary Outcome Measure Information:
Title
Quality of Life Using GERD-HRQL Scale
Description
The GERD-HRQL was initially developed to measure the typical symptoms of GERD and their effect on a patient's quality of life. It was initially determined to have face validity and subsequent studies assessed its content validity and criterion validity. Reliability was determined by the test-retest method. This instrument is practical, with little administrative burden and has been validated for use via the telephone call. Scale is 0-5 with 0 being no symptoms and 5 being symptoms are incapacitating.
Time Frame
pre-operative and 3 month and 6 month post surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of type 3 or 4 hiatal hernia (8)
Subject is able to give informed consent
Adults at least 18 years of age
Exclusion Criteria:
Currently pregnant
Prior hiatal hernia repair
Prior gastric surgery
Prior foregut surgery
Known esophageal dysfunction or dysmotility
Cirrhosis or ascites
Known malignancy
Known allergy to biologic mesh
Known allergy to barium or other contrast material used in UGI
Religious objection to animal implant
Cognitive impairment
Prisoners
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Levy, DO
Organizational Affiliation
Kettering Health Network
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kettering Health Network - Grandview Medical Center
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45405
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
23793804
Citation
Furnee E, Hazebroek E. Mesh in laparoscopic large hiatal hernia repair: a systematic review of the literature. Surg Endosc. 2013 Nov;27(11):3998-4008. doi: 10.1007/s00464-013-3036-y. Epub 2013 Jun 21.
Results Reference
background
PubMed Identifier
25785415
Citation
Lidor AO, Steele KE, Stem M, Fleming RM, Schweitzer MA, Marohn MR. Long-term quality of life and risk factors for recurrence after laparoscopic repair of paraesophageal hernia. JAMA Surg. 2015 May;150(5):424-31. doi: 10.1001/jamasurg.2015.25.
Results Reference
background
PubMed Identifier
18841422
Citation
Nason KS, Luketich JD, Qureshi I, Keeley S, Trainor S, Awais O, Shende M, Landreneau RJ, Jobe BA, Pennathur A. Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg. 2008 Dec;12(12):2066-75; discussion 2075-7. doi: 10.1007/s11605-008-0712-7. Epub 2008 Oct 8.
Results Reference
background
PubMed Identifier
25289348
Citation
Adelman DM, Selber JC, Butler CE. Bovine versus Porcine Acellular Dermal Matrix: A Comparison of Mechanical Properties. Plast Reconstr Surg Glob Open. 2014 Jun 6;2(5):e155. doi: 10.1097/GOX.0000000000000072. eCollection 2014 May.
Results Reference
background
PubMed Identifier
17439596
Citation
Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130-4. doi: 10.1111/j.1442-2050.2007.00658.x.
Results Reference
background
Citation
Radiologic Society of North America (2019). Radiation dose in X-Ray and CT Exam. Available at https://www.radiologyinfo.org/en/info.cfm?pg=safety-xray
Results Reference
background
Citation
K. S. Silvipriya, K. Krishna Kumar*, A. R. Bhat, B. Dinesh Kumar, Anish John, Panayappan Lakshmanan. Collagen: Animal Sources and Biomedical Application. Journal of Applied Pharmaceutical Science Vol. 5 (03), pp. 123-127, March, 2015. DOI: 10.7324/JAPS.2015.50322
Results Reference
background
PubMed Identifier
18656819
Citation
Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22(4):601-16. doi: 10.1016/j.bpg.2007.12.007.
Results Reference
background
Learn more about this trial
SurgiMend Mesh at the Hiatus
We'll reach out to this number within 24 hrs